Cognitive behaviour therapy as a treatment for irritable bowel syndrome: a pilot study
|
|
- Melvin Cummings
- 6 years ago
- Views:
Transcription
1 Cognitive behaviour therapy as a treatment for irritable bowel syndrome: a pilot study Philip Boyce, Jemma Gilchrist, Nicholas J. Talley, Donna Rose Objective: The irritable bowel syndrome (IBS) is a chronic and often disabling functional bowel disorder. Psychological treatments, in particular cognitive and behavioural interventions, have been shown to be effective for this disorder. The aim of this study was to test the efficacy of a cognitive behaviour program. Method: Eight participants (seven female, one male) aged between 24 and 71 years, with a diagnosis of IBS according to the Rome criteria, were recruited from among the gastroenterology outpatients at Nepean Hospital, in Sydney, Australia. Participants were administered pretreatment on measures of psychological function and bowel symptom severity. Following a 2-week baseline period, participants began a structured psychological treatment comprising eight sessions of cognitive behaviour therapy. Throughout treatment, participants maintained daily records of symptom severity and completed homework assignments to ensure treatment compliance. The pretreatment assessment measures were repeated 1 week post-treatment. Results: After treatment, five of the eight patients no longer met the Rome diagnostic criteria for IBS. There was no significant reduction in bowel symptom frequency. There were, however, significant improvements in the distress and disability associated with bowel symptoms. Anxiety and depression were also significantly reduced. Conclusions: Cognitive behaviour therapy reduced the distress and disability associated with IBS, but not the frequency of bowel symptoms. This supports the proposed cognitive model for IBS, and cognitive behaviour therapy appears to have its effect by altering the cognitive response to visceral hypersensitivity. Key words: cognitive behaviour therapy, functional bowel disorders, irritable bowel syndrome, somatisation. Australian and New Zealand Journal of Psychiatry 2000; 34: Irritable bowel syndrome (IBS) is a chronic, prevalent disorder for which there is a lack of effective Philip Boyce, Professor (Correspondence); Jemma Gilchrist, Research Psychologist, Donna Rose, Professor. Department of Psychological Medicine, The University of Sydney, Clinical Sciences Building, Nepean Hospital, PO Box 63, Penrith, New South Wales 2751, Australia. pboyce@mail.usyd.edu.au Nicholas J. Talley, Professor Department of Medicine, The University of Sydney, Nepean Hospital, Sydney, Australia Received 23 July 1999; second revision 15 December 1999; accepted 17 December treatment [1]. It results in considerable disability and increased health care utilisation among a subset of sufferers. It has been estimated that symptoms attributed to IBS may affect up to 15% of the population [2,3] and that 39% of patients with IBS take overthe-counter medications [3,4]. Despite the socioeconomic implications of IBS, little is known about its aetiology or pathophysiology and, as a consequence, medical management of the disorder remains unsatisfactory [5]. Irritable bowel syndrome is characterised by a chronically abnormal bowel habit in the absence of
2 P. BOYCE, J. GILCHRIST, N.J. TALLEY, D. ROSE 301 demonstrable pathology. To standardise the diagnosis of IBS, symptom-based criteria have been developed which are referred to as the Rome criteria [6]. For IBS symptoms to meet these criteria, there must be at least 3 months of continuous or recurrent abdominal pain or discomfort that is either relieved by defecation and/or is associated with a change in the frequency or consistency of the stools. In addition, there must be at least two of: a change in bowel habit, stool form or stool passage (straining, urgency or a feeling of incomplete evacuation); passage of mucus or feelings of bloating or abdominal distension. While there is some evidence to suggest that altered gut motility and changes in the sensation of the colon or small bowel occur in IBS [7 9], no distinct structural changes have been identified, suggesting that IBS may, in part, be functional in nature. Such a view is supported by the association between IBS and psychosocial variables, such as stress [1,10,11]. Further, persons suffering from IBS have high rates of comorbidity especially with anxiety and depression, particularly among those who present for treatment [12,13]. There is, however, some difficulty in interpreting the implications of the comorbidity between IBS and psychiatric disorders such as anxiety and depression. For example, although anxiety, via the autonomic nervous system, has effects on the gastrointestinal system and may, therefore, exacerbate pain, it is also reasonable to suggest that suffering the disabling IBS symptoms may make a person more likely to become anxious (or depressed). Thus, anxiety may be a cause or a consequence of gut disturbance. Alternatively, some common factor (such as neuroticism) may underlie both IBS and the comorbid psychiatric disorders. This assertion is supported by an observation that 79% of patients with IBS and comorbid panic disorder, generalised anxiety disorder or phobias reported that their anxiety symptoms predated their bowel dysfunction by weeks or even years [13,14]. Moreover, anxiety and depression are more common in sufferers of IBS than among patients with organic gastrointestinal disease [14]. Overall, the data suggest that there is a relationship between psychosocial problems, psychiatric disorders and IBS, at least among those who seek medical help for IBS. Further, there is an accepted lay-association between stress and IBS, such that psychological factors are recognised as its central feature. While the role of psychosocial factors in IBS has been difficult to determine, models have been proposed to explain such associations. Treatment approaches built upon these models have subsequently been developed. Drossman and Thompson [12] have emphasised the importance of psychosocial treatments in the management of IBS. Psychological treatments including dynamic psychotherapy, hypnotherapy, relaxation training, biofeedback and assertiveness training have been suggested for use in the management of IBS, but only some have been empirically evaluated (for summaries see [15 17]). A recent review of the literature on psychosocial treatments for IBS [18] indicated that 57% of the studies reported that psychosocial treatments were superior to control therapies. There were, however, significant methodological concerns about the studies, particularly in relation to subject recruitment, randomisation, placebo comparisons, failure to blind assessments and duration of follow up. The relationship between IBS and psychiatric disorder may be explained by combining individual models of IBS [12] and neurotic disorders [19] with a cognitive model of somatic disorders [20]. A core feature of the hypothesis is that there is a genetically determined visceral hypersensitivity in IBS which is central to its pathogenesis [21]. Irritable bowel syndrome sufferers may experience this visceral hypersensitivity generally; alternatively, among some, it may be linked to particular foods or stress. In the visceral hypersensitivity model, individuals with IBS are particularly vigilant and sensitive about visceral sensation and, as a result of their dysfunctional cognitive style, are more likely to interpret sensations as threatening. Perceiving such sensations as threatening will increase anxiety. This heightened anxiety has a direct effect on the gut which then, in a positive feedback loop, exacerbates the symptoms of IBS (see Fig. 1) and affects bowel habit. This relationship would be very similar to the recognised role of hypervigilance and dysfunctional cognitive style in the aetiology and maintenance of the anxiety disorders. Treatment approaches for IBS aim to reduce overall anxiety levels and, presumably, visceral hypersensitivity by both anxiety management strategies and modifying the dysfunctional cognitive style of the subject; anxiety-related symptoms may then be correctly labelled and symptom exacerbation, resulting from catastrophic misinterpretations, should be minimised. The effectiveness of cognitive behaviour therapy as a treatment for IBS has been reported in three controlled studies. Blanchard et al. [22] compared the impact of multi-component therapy (a combination of psychoeducation, relaxation training, biofeedback and cognitive stress coping training ) relative to placebo on GI symptoms. Although multi-component therapy
3 302 IRRITABLE BOWEL SYNDROME Figure 1. A proposed model for irritable bowel syndrome (IBS) which describes the relationship between visceral hypersensitivity, cognitive appraisal and IBS symptoms was effective, there was also evidence that an attention placebo was equally effective [22]. However, the attention placebo, which comprised biofeedback and pseudomeditation could be considered an active treatment. Greene and Blanchard [23] compared cognitive therapy with symptom monitoring as a placebo condition. Cognitive therapy was superior to symptom monitoring in reducing bowel symptoms, with the improvement being maintained at a 3-month follow up. Of particular note, increases in positive and reductions in negative automatic thoughts were reportedly associated with treatment gains, supporting the argument that IBS symptomatology is mediated by the individual s threatening perceptions of his or her physical health and environment. Finally, in a randomised controlled study of 34 IBS sufferers, Payne and Blanchard [24] compared individualised cognitive treatment, self-help support and a wait list control. Patients in the cognitive therapy condition demonstrated significantly greater improvement on measures of gastrointestinal symptoms, anxiety and depression than the remaining two conditions. Because of the public health importance of IBS and the lack of efficacious medical therapies, there is a need to develop an effective and practical psychological treatment for IBS. The purpose of the present study was to examine the effectiveness of a comprehensive cognitive behaviour treatment program, developed by the authors, in the treatment of IBS. Participants with a diagnosis of IBS each underwent a structured, eight-session, individual cognitive behaviour therapy which was designed to modify their appraisal, interpretation and ability to cope with bowel sensations, and what may have been perceived to be medically threatening stimuli. The impact of therapy on the participants health and wellbeing was assessed using self-report measures of bowel symptom severity and psychological morbidity. Method Participants All participants were recruited from among gastroenterology outpatients attending Nepean Hospital, Sydney, Australia. They were invited to participate if aged 18 years or over. Patient exclusion criteria included undergoing psychiatric treatment; taking antipsychotic, anxiolytic or antidepressant medication; concurrent physical or psychotic illness;
4 P. BOYCE, J. GILCHRIST, N.J. TALLEY, D. ROSE 303 history of alcoholism and insufficient literacy skills. Following appropriate tests to eliminate structural bowel dysfunction, the diagnosis of IBS was made according to the international Rome criteria [6] and written informed consent was obtained from all participants. Measures Participants were asked to complete a battery of measures of bowel-symptom severity and psychological distress at the baseline assessment. This battery consisted of a diagnostic instrument for functional bowel disease, the Structured Interview for Bowel Symptoms (SIBS) and a measure of bowel symptoms, the Bowel Symptom Severity Scale (BSSS). The SIBS is a structured interview developed at Nepean Hospital. It follows the same format of probing for symptoms as the widely used Composite International Diagnostic Interview (CIDI), and is used to determine the presence of functional bowel disease using the Rome criteria (over the previous 3 months). The frequency and degree to which bowel symptoms interfere with life and activities are also elicited in the SIBS. There is a high level of agreement between a SIBS diagnosis and that made by a gastroenterologist (a full validation study with blinded assessment comparing a gastroenterologist diagnosis with a SIBS diagnosis is underway). These interviews and administration of the questionnaires were conducted by an independent psychologist (DR) blind to the process of treatment. The Bowel Symptom Severity Scale provides a measure of frequency, disability and distress for each of the eight gastrointestinal symptoms associated with IBS (loose stools, hard stools, abdominal pain, bowel motion frequency, bloating, urgency to defecate, constipation and discomfort in the abdomen) over the previous week (see Appendix 1). Each of the symptoms is given a severity rating between 0 and 4, a higher rating being indicative of greater severity (with anchor points determined by the type of symptom). In addition to the SIBS and BSSS, participants also completed a daily self-report disability rating of abdominal pain, diarrhoea, constipation, belching, bloating, flatulence and nausea on a five-point Likert scale (from 0 = not a problem, to 4 = debilitating). To assess psychological wellbeing and disability, participants were asked to complete the Beck Depression Inventory (BDI [25]); the State Trait Anxiety Inventory (STAI [26]); and a well standardised measure of disability, the Medical Outcomes Study Short Form 36 (SF-36 [27]). Treatment protocol The cognitive behaviour treatment protocol was based on a cognitive model for hypochondriasis [20] and the treatment described by Greene and Blanchard [23]. A treatment manual, modelled on and incorporating parts of that produced by Andrews et al. [28] was written (full details are available from the authors). The treatment was conducted by a clinical psychologist trained in cognitive behaviour therapy (JG). The intervention consisted of the following eight components. Psychoeducation The treatment began with an explanation of the rationale for the therapeutic approach, particularly the relationship between cognition and feelings (both physical and emotional). Education was provided about the gastrointestinal system, the interaction between visceral sensation and dysfunctional thoughts and the role of diet and lifestyle factors in IBS. Participants were introduced to the cognitive, behavioural and physiological components of anxiety and, in particular, the impact of over-breathing and muscular tension in the precipitation and maintenance of the anxiety response. Anxiety management The participants were instructed on two anxiety management techniques; ventilation control and relaxation training. Participants were taught standard Progressive Muscle Relaxation (Jacobson, 1938) [29], with the aid of an audiotape, and isometric relaxation. Cognitive therapy Following Beck s model [30], participants were trained to identify anxiety-provoking dysfunctional thoughts, expectations and assumptions, both as they related to bowel symptoms and in general terms. Participants were then taught to challenge or modify errors in their thinking to produce more accurate, rational and helpful thoughts. Behavioural testing and graded exposure To illustrate the role of faulty predictions and avoidance in the maintenance of anxiety and IBS symptomatology, methods of using behaviour to test
5 304 IRRITABLE BOWEL SYNDROME predictions, and graded exposure techniques were introduced. For example, participants may predict that they are unable to attend or enjoy social functions when constipated, or to drive long distances for fear of diarrhoea. They were encouraged to gradually change their behaviour to confront such fears and challenge predictions. Dealing with worry Building on the cognitive techniques covered in the earlier part of the treatment program, participants were taught to use distraction, thought stopping, worry sessions, coping self-statements and cognitive restructuring as techniques to overcome excessive worrying. Problem solving As anxiety may result from unsatisfactory resolution of external events, specific problem-solving skills were included in the treatment program. This involved instruction on defining problems, brainstorming possible solutions, reviewing and choosing solutions and evaluating outcomes of strategies chosen to aid future problem solving. Relapse prevention To maintain therapeutic benefits, skills for coping with setbacks and lapses in progress were discussed with participants in the final treatment session. In addition to a manual with comprehensive written material on each treatment session, a detailed, structured workbook (for daily homework exercises) was given to each participant. The homework exercises included daily symptom monitoring, tension ratings for the relaxation exercise, monitoring of dysfunctional thoughts, problem solving, behavioural experiments and graded exposure exercises. Statistical analysis Paired t-tests were used to compare pre- and posttreatment scores on the BSSS, SF36, BDI and STAI. The alpha level of significance was set at p < 0.05; all p-values were two-tailed. Results Eight participants (seven female and one male), aged between 24 and 71 years (mean = 41 years and 8 months) participated in the study. Ten participants were initially recruited but one subject withdrew from the study because of the development of a concomitant physical illness and a second failed to complete treatment due to unavoidable circumstances. Gastrointestinal symptom frequency and severity We first examined changes in the number of bowel symptoms reported. Prior to treatment, the participants reported a mean of 6.75 (SD = 1.98) symptoms on the SIBS which had occurred in the previous month, which fell following treatment to 5.38 (SD = 2.78). However, the difference was non-significant. Responses to diagnostic questions on the SIBS were examined pre- and post-treatment. Five of the eight patients no longer met criteria for a diagnosis of IBS and two remained ill. One of the patients did not receive a diagnosis of IBS on the structured interview at pre- or post-treatment but, having been diagnosed by the physician at pretreatment, was included in the study. Responses to each of the eight gastrointestinal symptom frequency rating questions on the BSSS were given a score between 1 and 5 and then summed. Pretreatment, the mean rating of the frequency of bowel symptoms was 2.70 (SD = 0.47) and was not significantly different following treatment 2.17 (SD = 0.63) (see Table 1). Distress and disability associated with bowel symptoms The distress and disability associated with bowel symptoms were calculated by summing the severity ratings on the eight symptom areas of the BSSS. A significant reduction was evident in distress from a mean rating of 2.78 (SD = 0.91) to 1.52 (SD = 0.38) and disability from 2.57 (SD = 0.98) to 1.25 (SD = 0.38) (see Table 1). In addition to the clear face-validity of the BSSS, reliability analyses (conducted on this data) indicated that the scale has a high internal consistency (α = 0.88). Measures of anxiety and depression To compare pre- and post-treatment measures of both trait and state anxiety, ratings given to each of the 21 questions of the STAI (with anchors reversed where appropriate) were summed for each
6 P. BOYCE, J. GILCHRIST, N.J. TALLEY, D. ROSE 305 subscale. There was a significant post-treatment reduction in trait anxiety from 45.6 (SD = 10.1) to 35.0 (SD = 6.7), but not in state anxiety. There was also a significant reduction in mean score obtained on the BDI from 11.4 (SD = 5.9) to 4.3 (SD = 2.8) (see Table 1). Health function Significant changes over the course of treatment were evident in two of the subscales of the SF-36: mental health and health transition (see Table 1). Scores on physical function, bodily pain and general health also showed significant improvement with treatment. Scores on the remaining scales also improved, although the changes did not reach significance. The results are summarised in Table 1. Discussion Irritable bowel syndrome is a functional bowel disorder which, despite its prevalence and negative psychosocial impact, has eluded effective treatment [1]. We have carried out a pilot study of a cognitive behaviour treatment for IBS. This treatment is based on the premise that IBS symptoms are, in part, the result of dysfunctional cognitions about visceral sensation. The therapy was designed to educate participants about physical, cognitive and behavioural factors which contribute to IBS; to teach them methods of enhancing self-control over stress, anxiety and IBS symptoms; to correct dysfunctional thoughts (such as catastrophising visceral sensations) and to prevent symptom relapse. In this study we found that five of the eight participants did not meet criteria for a diagnosis of IBS at the conclusion of treatment. However, while there was a reduction in symptom frequency this failed to reach significance. This discrepancy may be a result of the different assessment measures. While the BSSS assesses the frequency of discrete bowel symptoms (such as loose stools or abdominal pain), the structured interview considers frequency in the context of other bowel symptoms. For example, it enquires about the frequency of a change in stool form at times when abdominal pain was present. Table 1. Mean scores obtained on each assessment measure pre- and post-treatment and summary of t-test statistics Assessment measure Pretreatment Post-treatment Mean SD Mean SD t df p BSSS Frequency Distress ** Disability ** Anxiety (STAI) State Trait ** Depression (BDI) ** SF-36 Subscale Physical functioning * Role functioning (physical) Role functioning (emotional) Bodily pain * General health * Vitality Social functioning Mental health ** Health transition * BDI, Beck Depression Inventory; BSSS, Bowel Symptom Severity Scale; SF-36, Medical Outcomes Study Short Form 36; STAI, State Trait Anxiety Inventory. Following SF-36 scoring recommendations, all raw scores have been transformed to scale. In all scales except Health Transition, a higher score is indicative of higher functioning or health state. * significant at p < 0.05; ** significant at p < 0.01.
7 306 IRRITABLE BOWEL SYNDROME Discrete bowel symptoms are insufficient to warrant a diagnosis of IBS which, according to the Rome criteria, should be based on an association between particular bowel symptoms within a given time period. Perhaps the most salient finding in the present study was that the participants reported significant reductions in the amount of distress and disability associated with their symptoms. They also reported improvements in their physical functioning, pain and general and mental health. Improvements were also evident in reductions in generalised anxiety and depressive symptomatology. This suggests that while the bowel disturbance was not substantially reduced by this treatment, the participants became less concerned about the symptoms and that both their daily life and mental health improved. There was some reduction in symptoms that could be attributed to the reduction in anxiety about bowel function. This would have an effect in reducing autonomic changes in the bowel and tend to normalise bowel activity. Even a small change in symptom frequency would have a positive effect in reducing anxiety. A recent paper by Bennett et al. [10] reported that chronic life stress predicted the intensity of bowel symptoms. Intensity was calculated as the product of symptom frequency and severity (which was based on whether remedies had been sought and the degree of disturbance to daily activity). The measures of distress and disability used in the present study, when combined, could be considered similar to the severity measure employed by Bennet et al. [10]. Had we calculated a measure of intensity, we may have found a reduction in the intensity of bowel symptoms following treatment, despite there being no reduction in symptom frequency. The observations of Barrett et al. that symptom intensity is predicted by life stressors, supports the premise that our cognitive behaviour treatment may have affected bowel symptoms by enhancing general stress management skills and reducing the impact of chronic stressors. Our results are also consistent with, for example, psychosocial treatments for chronic pain, in which the treatments are variably effective in the alleviation of pain, but which often result in improved quality of life and reduced pain-related disability [31]. The findings of this study offer some support for the cognitive model of IBS. The participants were reportedly less troubled by their symptoms and, given our proposition that visceral hypersensitivity in IBS has a genetically determined biological predisposition, the reduced distress is likely to be attributable to changing cognition, which reduces the impact of this visceral sensitivity. Whether changes in cognition related to visceral sensation produced changes in psychological wellbeing, or vice versa, requires clarification. Regardless, if it is the case that psychological dysfunction is a predisposing as well as a maintaining feature of IBS [14], the reduction in generalised anxiety and depressive symptoms demonstrated here may be a powerful relapse prevention strategy. The purpose of the study was to pilot a psychological treatment program for IBS. The finding of this study suggest that cognitive behaviour intervention is an effective treatment for IBS. There are however, limitations in this pilot study: a small sample size and no control group. These limitations are acknowledged. However, the purpose of this pilot study was to establish the effectiveness of the treatment package described and this was clearly achieved. Of course, the findings will need to be replicated in a randomised, controlled study before more definitive statements can be made about the package s general efficacy. Notwithstanding previous reports that psychological interventions [12], particularly cognitive behaviour therapy, are effective treatments [22,23], the depth of knowledge is currently inadequate to set out in guidelines for optimum health care in IBS. We believe that continued investigation of a variety of psychological management approaches is required to determine the most effective and practically viable treatment. Acknowledgement This study was supported in part by a seeding grant from the Faculty of Medicine, University of Sydney. References 1. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: Jones R, Lydeard S. Irritable bowel syndrome in the general population. British Medical Journal 1992; 304: Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990; 99: Klein KB. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988; 95: Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G. Functional bowel disease and functional abdominal disease. Gastroenterology International 1992; 5:75 91.
8 P. BOYCE, J. GILCHRIST, N.J. TALLEY, D. ROSE Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987; 92: Lynn RB, Friedman LS. Irritable bowel syndrome. New England Journal of Medicine 1993; 329: Lembo T, Munakata J, Niazi N et al. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology 1994; 107: Bennett EJ, Tennant CC, Piesse C, Badcock C-A. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998; 43: Levy RL, Cain KC, Jarrett M, Heitkemper M. The relationship between daily life stress and gastro intestinal symptoms in women with IBS. Journal of Behavioural Medicine 1997; 20: Drossman DA, Thompson WG. The irritable bowel syndrome: a review and a graduated multicomponent treatment approach. Annals of Internal Medicine 1992; 116: Walker EA, Roy-Byrne PP, Katon WJ. Irritable bowel syndrome and psychiatric illness. American Journal of Psychiatry 1990; 147: Creed F. Relationship of non-organic abdominal pain to psychiatric disorder and life stress. In: Creed F, Mayou R, Hopkins A, eds. Medical symptoms not explained by organic disease. Washington: American Psychiatric Press, 1992: Whitehead WE, Crowell MD. Psychologic considerations in the irritable bowel syndrome. Gastroenterology Clinics of North America 1991; 20: Blanchard EB, Schwartz SP, Radnitz CR. Psychological assessment and treatment of irritable bowel syndrome. Behaviour Modification 1987; 11: Goldberg J, Davidson P. A biopsychosocial understanding of the irritable bowel syndrome: a review. Canadian Journal of Psychiatry 1997; 42: Talley N, Owen B, Boyce P, Paterson K. Psychological treatment for irritable bowel syndrome: a critique of controlled treatment trials. American Journal of Gastroenterology 1996; 91: Andrews H, Barczak P, Allan R. Psychiatric illness in patients with inflammatory bowel disease. Gut 1987; 12: Salkovskis PM. Somatic problems. In: Hawton K, Salkovskis P, Kirk J, Clark DM, eds. Cognitive behaviour therapy for psychiatric problems. Oxford: Oxford University Press, Morris-Yates A, Talley N, Boyce P, Nandurkar S, Andrews G. Evidence of a genetic contribution to functional bowel disorder. The American Journal of Gastroenterology 1998; 93: Blanchard EB, Schwartz SP, Suls JM et al. Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome. Behaviour Research and Therapy 1991; 30: Greene B, Blanchard EB. Cognitive therapy for irritable bowel syndrome. Journal of Consulting and Clinical Psychology 1994; 62: Payne A, Blanchard EB. A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. Journal of Consulting and Clinical Psychology 1995; 63: Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961; 4: Spielberger CD. Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press, Ware JE, Sherbourne CD. The MOS 36-item Short-form Health Survey (SF-36). I: conceptual framework and item selection. Medical Care 1992; 30: Andrews G, Crino R, Hunt C, Lampe L, Page A. The treatment of anxiety disorders. New York: Cambridge University Press, Jacobson E. Progressive relaxation. Chicago: University of Chicago Press, Beck AT. Cognitive therapy: nature and relation to behaviour therapy. Behaviour Therapy 1970; 1: Gamsa A. The role of psychological factors in chronic pain. I: a half century of study. Pain 1994; 57:5 15. Appendix 1 BOWEL SYMPTOM SEVERITY SCALE Subject No. Date / / General Instructions Please indicate below, how often you have had each symptom of bowel disease over the past week. Do this by placing a cross neatly in the box. If you do not have the symptom place a cross in the not at all box. Please ensure you answer all of the questions. 1a. Over the past week how often have you had loose or watery bowel motions? Not at all Every other day Every day 1 3 times a day More than 3 times a day 1b. How distressed were you by this? 1c. How much did this interfere with your everyday life?
9 308 IRRITABLE BOWEL SYNDROME 2a. Over the past week on how many occasions did you have hard or lumpy stools when you had a bowel motion? Not at all Once or twice 3 5 times Every day More than once a day 2b. How distressed were you by this? 2c. How much did this interfere with your everyday life? 3a. Over the past week how often have you had abdominal (tummy) pain? Not at all Once or twice 3 5 times Every day More than once a day 3b. How distressed were you by this? 3c. How much did this interfere with your everyday life? 4a. Over the past week, on how many days have you had more than 3 bowel motions a day? Not at all b. How distressed were you by this? 4c. How much did this interfere with your everyday life? 5a. Over the past week, how often have you felt bloated or had an uncomfortable fullness in your abdomen? Not at all Once or twice 3 5 times Every day More than once a day 5b. How distressed were you by this? 5c. How much did this interfere with your everyday life?
10 P. BOYCE, J. GILCHRIST, N.J. TALLEY, D. ROSE 309 6a. Over the past week how often have you had an urgent need to have a bowel motion? Not at all Once or twice 3 5 times Every day More than once a day 6b. How distressed were you by this? 6c. How much did this interfere with your everyday life? 7a. Over the past week, how many days have there been when you were unable to have a bowel motion? Not at all b. How distressed were you by this? 7c. How much did this interfere with your everyday life? 8a. Over the past week, how often have you had a general feeling of discomfort in your abdomen (tummy)? Not at all Once or twice 3 5 times Every day More than once a day 8b. How distressed were you by this? 8c. How much did this interfere with your everyday life?
... SELECTED ABSTRACTS...
... SELECTED ABSTRACTS... The following abstracts, from medical journals containing literature on irritable bowel syndrome, were selected for their relevance to this supplement. A Technical Review for
More informationAcknowledgements. Illness Behavior A cognitive and behavioral phenomenon. Seeking medical care. Communicating pain to others
Acknowledgements Parent Training to Address Pediatric Functional Abdominal Pain: A Researcher s Perspective Dr. Kim Swanson National Institutes of Health Rona L. Levy, MSW, PhD, MPH Professor and Director
More informationUKLIN1693a, date of preparation: March 2013.
1 This table shows the ICE model. Defining the patient s ideas, concerns, and expectations is an important part of the consultation that can lead to better outcomes. 2 Patients with IBS may have visceral
More informationIrritable Bowel Syndrome and Mood Disorders Pedro Ramos, University of Louisville, Louisville, KY
Paper P06-2009 Irritable Bowel Syndrome and Mood Disorders Pedro Ramos, University of Louisville, Louisville, KY ABSTRACT This case study describes the use of SAS technology in streamlining cross-sectional
More informationFUNCTIONAL GASTROINTESTINAL DISORDERS: RELATIONS BETWEEN PSYCHOSOCIAL FACTORS, SYMPTOMS AND SENSORIMOTOR DISTURBANCE
FUNCTIONAL GASTROINTESTINAL DISORDERS: RELATIONS BETWEEN PSYCHOSOCIAL FACTORS, SYMPTOMS AND SENSORIMOTOR DISTURBANCE ETHELLE JEANETTE BENNETT BA (HONS) A thesis submitted in fulfilment of the requirements
More informationMetacognitive therapy for generalized anxiety disorder: An open trial
Journal of Behavior Therapy and Experimental Psychiatry 37 (2006) 206 212 www.elsevier.com/locate/jbtep Metacognitive therapy for generalized anxiety disorder: An open trial Adrian Wells a,, Paul King
More informationDrossman Gastroenterology 55 Vilcom Center Drive Boyd Hall, Suite 110 Chapel Hill, NC 27514
Drossman Gastroenterology 55 Vilcom Center Drive Boyd Hall, Suite 110 Chapel Hill, NC 27514 History of Functional Disorders Douglas A. Drossman, MD Melissa Swantkowski THE PAST HISTORICAL PRECEDENTS Historians
More informationIBS - Definition. Chronic functional disorder of GI generally characterized by:
IBS - Definition Chronic functional disorder of GI generally characterized by: 3500 3000 No. of Publications 2500 2000 1500 1000 Irritable Bowel syndrome Irritable Bowel Syndrome 500 0 1968-1977 1978-1987
More informationAlternating bowel pattern: what do people mean?
Alimentary Pharmacology & Therapeutics Alternating bowel pattern: what do people mean? R. S. CHOUNG*, G. R. LOCKE III*, A. R. ZINSMEISTER, L.J.MELTONIIIà &N.J.TALLEY* *Dyspepsia Center and Division of
More informationCHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University
CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University 1 Definition of FGID Chronic and recurrent symptoms of the gastrointestinal
More information9 BEHAVIOURAL THERAPIES
PART BEHAVIOURAL THERAPIES Clinical Questions. Does CBT have a role in managing symptoms?. Do psychological interventions have a role in managing symptoms?. Does hypnotherapy have a role in managing IBS
More informationFUNCTIONAL DISORDERS TREATMENT ADVANCES. Dr. Adriana Lazarescu MD FRCPC Director GI Motility Lab, Edmonton Associate Professor University of Alberta
FUNCTIONAL DISORDERS TREATMENT ADVANCES Dr. Adriana Lazarescu MD FRCPC Director GI Motility Lab, Edmonton Associate Professor University of Alberta Name: Dr. Adriana Lazarescu Conflict of Interest Disclosure
More informationGastrointestinal Society 2016 SURVEY RESULTS
Gastrointestinal Society 2016 SURVEY RESULTS Irritable Bowel Syndrome (IBS) The GI (Gastrointestinal) Society represents Canadians living with gastrointestinal diseases and disorders including those who
More informationPredictors of health care seeking for irritable bowel syndrome: a population based study
394 Departments of Medicine and Psychological Medicine, University of Sydney, Nepean Hospital, PO Box 63, Penrith, NSW, Australia N J Talley PMBoyce M Jones Correspondence to: Dr N J Talley, Professor
More informationPrevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population
https://helda.helsinki.fi Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population Hillilä, M. T. 2004-08-01 Hillilä, M T & Färkkilä, MA 2004,
More informationBehavioural and Cognitive Psychotherapy, 1998, 26, Cambridge University Press. Printed in the United Kingdom
Behavioural and Cognitive Psychotherapy, 1998, 26, 87 91 Cambridge University Press. Printed in the United Kingdom Brief Clinical Reports TRAIT ANXIETY AS A PREDICTOR OF BEHAVIOUR THERAPY OUTCOME IN SPIDER
More informationIBS: overview and assessment of pain outcomes and implications for inclusion criteria
IBS: overview and assessment of pain outcomes and implications for inclusion criteria William D. Chey, MD Professor of Medicine University of Michigan What is the Irritable Bowel Syndrome Symptom based
More informationJournal of Anxiety & Depression
Journal of Anxiety & Depression Case Report Vol 1 Iss 1 Biofeedback treatment of Mixed Anxiety Depressive disorder: A case report Richa Priyamvada 1, Rupesh Ranjan 2 and Suparkash Chaudhury 3* 1 Department
More informationIBS is associated with an increased incidence of psychological
Does Depression Influence Symptom Severity in Irritable Bowel Syndrome? Case Study of a Patient With Irritable Bowel Syndrome and Bipolar Disorder CATHERINE CRANE, BA, MARYANNE MARTIN, MA, DPHIL, DEREK
More informationValidated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population
Aliment Pharmacol Ther 2005; 22: 483 488. doi: 10.1111/j.1365-2036.2005.02621.x Validated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population A. O. O.
More informationSUPPLEMENTARY INFORMATION Associated with
Table1: Rome III and Rome IV diagnostic criteria for IBS, functional constipation and functional dyspepsia. Rome III diagnostic criteria 1,2 Rome IV diagnostic criteria 3,4 Diagnostic criteria for IBS
More informationSelective serotonin reuptake inhibitors for the management of irritable bowel syndrome: A meta-analysis of randomized controlled trials
Clinical research Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: A meta-analysis of randomized controlled trials Roja Rahimi 1, Shekoufeh Nikfar 2, Mohammad Abdollahi
More informationSTRESS CONTROL LARGE GROUP THERAPY FOR GENERALIZED ANXIETY DISORDER: TWO YEAR FOLLOW-UP
Behavioural and Cognitive Psychotherapy, 1998, 26, 237 245 Cambridge University Press. Printed in the United Kingdom STRESS CONTROL LARGE GROUP THERAPY FOR GENERALIZED ANXIETY DISORDER: TWO YEAR FOLLOW-UP
More informationChronic Fatigue Syndrome (CFS) / Myalgic Encephalomyelitis/Encephalopathy (ME)
Chronic Fatigue Syndrome (CFS) / Myalgic Encephalomyelitis/Encephalopathy (ME) This intervention (and hence this listing of competences) assumes that practitioners are familiar with, and able to deploy,
More informationPanic Control Therapy (PCT) 1 Barlow model
Problem-specific competences describe the knowledge and skills needed when applying CBT principles to specific conditions. They are not a stand-alone description of competences, and should be read as part
More informationPATIENTS ILLNESS PERCEPTIONS Do they matter and can we change them
PATIENTS ILLNESS PERCEPTIONS Do they matter and can we change them Rona Moss-Morris Professor of Psychology as Applied to Medicine Institute of Psychiatry, Psychology and Neuroscience Section of Health
More informationMANAGEMENT OF VISCERAL PAIN
MANAGEMENT OF VISCERAL PAIN William D. Chey, MD, FACG Professor of Medicine University of Michigan 52 year old female with abdominal pain 5 year history of persistent right sided burning/sharp abdominal
More informationT he irritable bowel syndrome (IBS) is a symptom complex
1703 FUNCTIONAL BOWEL DISEASE Familial aggregation of irritable bowel syndrome: a prospective study J S Kalantar, G R Locke III, A R Zinsmeister, C M Beighley, N J Talley... Gut 2003;52:1703 1707 See end
More informationWhen the Stomach loses the Head
When the Stomach loses the Head Creative dealing with Irritable Bowel Syndrome (IBS) The V European Congress of Ericksonian Hypnosis and Psychotherapy Krakow June 12-15, 2014 Brigitta Loretan-Meier Master
More informationThe long-term impact of the low-fodmap diet for management of irritable bowel syndrome. Dr Miranda Lomer RD.
The long-term impact of the low-fodmap diet for management of irritable bowel syndrome Dr Miranda Lomer RD Email: miranda.lomer@kcl.ac.uk What is IBS - ROME IV Criteria A functional bowel disorder in which
More informationA Prospective Assessment of Bowel Habit in Irritable Bowel Syndrome in Women: Defining an Alternator
GASTROENTEROLOGY 2005;128:580 589 A Prospective Assessment of Bowel Habit in Irritable Bowel Syndrome in Women: Defining an Alternator DOUGLAS A. DROSSMAN,* CAROLYN B. MORRIS,* YUMING HU,* BRENDA B. TONER,
More informationWeekly Prevalence of Symptoms USA vs. Colombia
THE OVERLAP BETWEEN INFLAMMATORY BOWEL DISEASE AND FUNCTIONAL GASTROINTESTINAL DISORDERS: CHALLENGES AND TREATMENT IMPLICATIONS Miguel Saps, MD Professor of Pediatrics, Ohio State University Director of
More informationAre psychological treatments of panic disorder efficacious?
Are psychological treatments of panic disorder efficacious? Peter Wilhelm 7.3.2018 PD Dr. Peter Wilhelm, Spring 2018 1 Efficacy of Behavioral Treatment of Panic Disorder First randomised controlled trial
More informationPrevalence and demographics of irritable bowel syndrome: results from a large web-based survey
Aliment Pharmacol Ther 2005; 22: 935 942. doi: 10.1111/j.1365-2036.2005.02671.x Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey E. B. ANDREWS*, S. C. EATON*,
More informationPrevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria
ORIGINAL RESEARCH Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria Hiroto Miwa Division of Upper Gastroenterology, Department of Internal Medicine, Hyogo College
More informationIndividual Planning: A Treatment Plan Overview for Individuals with Somatization Disorder
COURSES ARTICLE - THERAPYTOOLS.US Individual Planning: A Treatment Plan Overview for Individuals with Somatization Disorder Individual Planning: A Treatment Plan Overview for Individuals with Somatization
More informationDavid Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure:
David Leff, DO AOMA 94 th Annual Convention April 13, 2016 Disclosure I have the following financial relationships to disclosure: Speaker s Bureau: Allergan Labs, Takeda Pharmaceutical, Valeant Pharmaceutical
More informationIrritable Bowel Syndrome. Mustafa Giaffer March 2017
Irritable Bowel Syndrome Mustafa Giaffer March 2017 Introduction First described in 1771. 50% of patients present
More informationThe Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale
Aliment Pharmacol Ther 2004; 20: 89 97. doi: 10.1111/j.1365-2036.2004.02007.x The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale J. S. LABUS*,,
More informationIs Physical Activity Effective In Reducing The Gastrointestinal Symptoms Associated with Irritable Bowel Syndrome?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2018 Is Physical Activity Effective In Reducing
More informationDiagnostic value of the Manning criteria in irritable bowel syndrome
Gut, 1990, 31, 77-81 Diagnostic value of the Manning criteria in irritable bowel syndrome 77 N J Talley, S F Phillips, L J Melton, C Mulvihill, C Wiltgen, A R Zinsmeister Gastroenterology Unit, Mayo Clinic
More informationComplementary and Alternative Medicine for IBS in Adults: Mind-Body Interventions
Complementary and Alternative Medicine for IBS in Adults: Mind-Body Interventions David J. Kearney; Janelle Brown-Chang http://www.medscape.com/viewarticle/583420 Authors and Disclosures Posted: 11/13/2008;
More informationThe Leeds Teaching Hospitals NHS Trust Irritable Bowel Syndrome
n The Leeds Teaching Hospitals NHS Trust Irritable Bowel Syndrome Information for patients Irritable bowel syndrome (IBS) is a common, long term condition of the digestive system (gut). It causes episodes
More informationWOMEN WITH IRRITABLE BOWEL SYNDROME ACCORDING TO ROME II CRITERIA IN JORDAN
Original Article WOMEN WITH IRRITABLE BOWEL SYNDROME ACCORDING TO ROME II CRITERIA IN JORDAN Kassab Harfoushi 1 ABSTRACT Objectives: To characterize the possible risk factors, clinical features and outcome
More informationIBS. Patient INFO. A Guide to Irritable Bowel Syndrome
Patient INFO IBS A Guide to Irritable Bowel Syndrome The information provided by the AGA Institute is not medical advice and should not be considered a replacement for seeing a medical professional. About
More informationModule 4: Case Conceptualization and Treatment Planning
Module 4: Case Conceptualization and Treatment Planning Objectives To better understand the role of case conceptualization in cognitive-behavioral therapy. To develop specific case conceptualization skills,
More informationIrritable Bowel Syndrome Now. George M. Logan, MD Friday, May 5, :35 4:05 PM
Irritable Bowel Syndrome Now George M. Logan, MD Friday, May 5, 2017 3:35 4:05 PM Dr. Logan indicated no potential conflict of interest to this presentation. He does not intend to discuss any unapproved/investigative
More informationWhat is Irritable Bowel Syndrome (IBS)?
What is Irritable Bowel Syndrome (IBS)? Irritable bowel syndrome (IBS) is a health issue found in your intestines (gut). IBS can cause symptoms such as: Belly pain. Cramping. Gas. Bloating (or swelling)
More informationCBT for Hypochondriasis
CBT for Hypochondriasis Ahmad Alsaleh, MD, FRCPC Assistant Professor of Psychiatry College of Medicine, KSAU-HS, Jeddah Agenda Types of Somatoform Disorders Characteristics of Hypochondriasis Basic concepts
More informationLive patient discussion Sandra Ros (MA), Dr Lluís Puig
Department of Dermatology Hospital de la Santa Creu i Sant Pau op yr ig ht I P C N O V A R T I S P S O R I A S I S P R E C E P T O R S H I P C Live patient discussion Sandra Ros (MA), Dr Lluís Puig Barcelona,
More informationIrritable Bowel Syndrome: Toward an Understanding of Severity
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:717 725 REVIEW Irritable Bowel Syndrome: Toward an Understanding of Severity ANTHONY LEMBO,* VANESSA Z. AMEEN, and DOUGLAS A. DROSSMAN *Beth Israel Deaconess
More informationFamily-centered Stress Management for Childhood Cancer: A Multimodal Intervention for Children Newly Diagnosed with Cancer and their Families
Family-centered Stress Management for Childhood Cancer: A Multimodal Intervention for Children Newly Diagnosed with Cancer and their Families Linda Ewing, Ph.D., RN Department of Psychiatry University
More informationFunctional Heartburn and Dyspepsia
Functional Heartburn and Dyspepsia Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina Objectives Understand the means of diagnosing functional heartburn
More informationCOMORBIDITY OF IRRITABLE BOWEL SYNDROME, PANIC DISORDER, AND AGORAPHOBIA IN THE GENERAL POPULATION IN JAPAN
COMORBIDITY OF IRRITABLE BOWEL SYNDROME, PANIC DISORDER, AND AGORAPHOBIA IN THE GENERAL POPULATION IN JAPAN HIROAKI KUMANO, M.D. 1,2) Hisanobu Kaiya M.D. 1,2) Gaku Yamanaka M.D. 1,2,3) Tomifusa Kuboki
More informationIrritable bowel syndrome (IBS) is a ... PRESENTATION... Defining and Diagnosing Irritable Bowel Syndrome
... PRESENTATION... Defining and Diagnosing Irritable Bowel Syndrome Based on a presentation by Marvin M. Schuster, MD Presentation Summary Approximately 20% of the general population has irritable bowel
More informationAre Somatisation Disorders any use to clinicians or patients? February 13th 2013 Charlotte Feinmann
Are Somatisation Disorders any use to clinicians or patients? February 13th 2013 Charlotte Feinmann Outline Context and Definitions Changing Classification Changing Medical Attitudes Understanding Psychological
More informationThis is because the situation is demystified and the element of fear of the unknown is eliminated.
This is more or less along the lines of the strategies we have already discussed for stress. These include common sense measures such as engaging in healthy lifestyle activities: exercising, eating well,
More informationManaging Panic Disorder with Cognitive Behavior Therapy in Bangladesh: A Single Case Study
Managing Panic Disorder with Cognitive Behavior Therapy in Bangladesh: A Single Case Study Shahanur Hossain M. Phil part-ii, Dept. of Clinical psychology, University of Dhaka, Bangladesh. What is panic
More informationDOWNLOAD OR READ : IRRITABLE BOWEL SYNDROME ONE DISEASE SEVERAL OR NONE PERSPECTIVES IN DIGESTIVE DISEASES VOL 5 PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : IRRITABLE BOWEL SYNDROME ONE DISEASE SEVERAL OR NONE PERSPECTIVES IN DIGESTIVE DISEASES VOL 5 PDF EBOOK EPUB MOBI Page 1 Page 2 irritable bowel syndrome one disease several or none perspectives
More informationBowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care
Bowel cancer risk in the under 50s Greg Rubin Professor of General Practice and Primary Care Prevalence of GI problems in the consulting population Thompson et al, Gut 2000 Number of patients % of patients
More informationAntidepressant Medication use is Associated with Abdominal Symptoms in People without a Functional Gastrointestinal Diagnosis
Antidepressant Medication use is Associated with Abdominal Symptoms in People without a Functional Gastrointestinal Diagnosis Heenan PE, Keenan JI, Roy NC, Gearry RB Introduction Functional Gastrointestinal
More informationTHE LONG TERM PSYCHOLOGICAL EFFECTS OF DAILY SEDATIVE INTERRUPTION IN CRITICALLY ILL PATIENTS
THE LONG TERM PSYCHOLOGICAL EFFECTS OF DAILY SEDATIVE INTERRUPTION IN CRITICALLY ILL PATIENTS John P. Kress, MD, Brian Gehlbach, MD, Maureen Lacy, PhD, Neil Pliskin, PhD, Anne S. Pohlman, RN, MSN, and
More informationThe effectiveness of empowerment workshops with torture survivors
9 The effectiveness of empowerment workshops with torture survivors Penelope Curling, MA* Abstract The article explores the effectiveness of the use of an empowerment workshop, called Free to Grow 1 (FTG),
More informationIrritable bowel syndrome in general practice: prevalence, characteristics, and referral
78 Gut 2000;46:78 82 Division of Gastroenterology, University of Ottawa, Ottawa, Canada W G Thompson University Division of Medicine, Bristol Royal Infirmary, Bristol, UK K W Heaton C Smyth Department
More informationThe relationship between FODMAP intake and acute gastrointestinal symptoms in adults with IBS A novel analysis using the FAST Diary
The relationship between FODMAP intake and acute gastrointestinal symptoms in adults with IBS A novel analysis using the FAST Diary Macintosh A 1, Wright-McNaughton M 1, Frampton C 2, Skidmore P 1, Gearry
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Constipation: the diagnosis and management of idiopathic childhood constipation in primary and secondary care 1.1 Short title
More informationAt the outset, we want to clear up some terminology issues. IBS is COPYRIGHTED MATERIAL. What Is IBS?
1 What Is IBS? At the outset, we want to clear up some terminology issues. IBS is the abbreviation that doctors use for irritable bowel syndrome, often when they are talking about people with IBS. We will
More informationImpact of functional gastrointestinal disorders on health-related quality of life: a population-based case control study
Aliment Pharmacol Ther 2004; 19: 233 242. doi: 10.1111/j.0269-2813.2004.01807.x Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case control study
More informationStudies have shown that familial aggregation is of
No Evidence of Sex Differences in Heritability of Irritable Bowel Syndrome in Swedish Twins Pia Svedberg, 1 Saga Johansson, 3,4 Mari-Ann Wallander, 3,6 and Nancy L. Pedersen 2,5 1 Section of Personal Injury
More informationEuropean Scientific Journal April 2018 edition Vol.14, No.12 ISSN: (Print) e - ISSN
Assessment of the Effectiveness of Health Education for Ibs Women by Examining the Frequency and Disturbance of Gi Symptoms, Quality of Life and Days of Drug Use Hsiu-Chin Lin, (MSN, RN) National Taipei
More informationCharité-Universitätsmedizin Berlin, Campus Mitte 2 Department of Medicine and Institute of Neurogastroenterology, Martin-Luther-Hospital
14 Prognostic Relevance of Subjective Theories of Illness on the Clinical and Psychological Parameters in Irritable Bowel Syndrome Patients A Longitudinal Study A. Riedl 1, J. Maass 1, A. Ahnis 1, A. Stengel
More information11/15/2017. Disclosure. What is an EAP and History of Biofeedback at UCLA s Staff and Faculty Counseling Center
From Good to Great: The Use of Biofeedback in Employee Assistance Programs as a Tool to Build Resilience in the Workplace by: Dr. J. Cherbosque. PhD, CEAP, Dr. S. Sideroff, PhD, and Beth Argus, MFT, CEAP
More informationProf. Dr. Mufti Munsurar Rahman Dept. of Medicine Enam Medical College Hospital
Prof. Dr. Mufti Munsurar Rahman Dept. of Medicine Enam Medical College Hospital Functional constipation : prevalence and life style factors in a district of Bangladesh Perveen I, Rahman MM, Saha M, Parvin
More informationCoping with Advanced Stage Heart Failure and LVAD/Transplant. Kristin Kuntz, Ph.D. Department of Psychiatry and Behavioral Health
Coping with Advanced Stage Heart Failure and LVAD/Transplant Kristin Kuntz, Ph.D. Department of Psychiatry and Behavioral Health What is Health Psychology? Health psychology focuses on how biology, psychology,
More informationSomatization,Somatoform disorders, and functional somatic syndromes: Prepared by Dr John Potokar Senior Lecturer Liaison Psychiatry UOB
Somatization,Somatoform disorders, and functional somatic syndromes: Prepared by Dr John Potokar Senior Lecturer Liaison Psychiatry UOB Topic relevant to all clinical disciplines in medicine/surgery/primary
More informationProfessional Hypnotherapy & Hypnosis Training. Hypnotherapy & Hypnosis For IBS (Irritable Bowel Syndrome)
Professional Hypnotherapy & Hypnosis Training Hypnotherapy & Hypnosis For IBS (Irritable Bowel Syndrome) What Is IBS? (Irritable Bowel Syndrome) IBS is the term for a collection of symptoms that may include:
More informationIrritable Bowel. Syndrome. Health Promotion Service
The information in this leaflet is not intended to replace the knowledge or diagnosis of a qualified health practitioner. We encourage you to consult a health professional and ensure your IBS is properly
More informationLow FODMAP Dietary Approach For FGD/IBS. Our Experience. Charlotte McCamphill 19 th February 2015
Low FODMAP Dietary Approach For FGD/IBS Our Experience Charlotte McCamphill 19 th February 2015 CONTENTS What Is IBS What are FODMAPs Service Provision Audit Results Future Work WHAT IS IBS The Rome III
More informationALI GHOLAMREZAEI, 1,2 SAMANEH KHANPOUR ARDESTANI, 1 and MOHAMMAD HASAN EMAMI 2,3 ABSTRACT
THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 12, Number 6, 2006, pp. 517 527 Mary Ann Liebert, Inc. Where Does Hypnotherapy Stand in the Management of Irritable Bowel Syndrome? A Systematic
More informationSpecific Phobia. An ability to help the client to complete relevant self-monitoring records for use throughout the intervention.
Specific Phobia Sources: Butler, G. (1989) Phobic disorders pp 97-128 in K. Hawton, P.M. Salkovskis, J. Kirk and D.M. Clark Cognitive Behaviour Therapy for psychiatric problems: A practical guide Oxford:
More informationCognitive change in patients undergoing hypnotherapy for irritable bowel syndrome
Journal of Psychosomatic Research 56 (2004) 271 278 Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome Wendy M. Gonsalkorale a, *, Brenda B. Toner b, Peter J. Whorwell a
More informationUncomplicated diverticular disease is not a common cause of colonic symptoms
Alimentary Pharmacology and Therapeutics Uncomplicated diverticular disease is not a common cause of colonic symptoms J. Y. Kang*, B. Firwana*, A. E. Green*, H. Matthews*, A. Poullis*, A. Barnabas*, L.
More informationHow My Field Works with IBS & What You Can Do to Help Your Clients Regain Control.
How My Field Works with IBS & What You Can Do to Help Your Clients Regain Control. hello! Eva M Clark, Medical Hypnotherapist www.mindbasedhealing.org 577 Soquel Ave. Santa Cruz, CA 95062 2 Why Irritable
More informationTana's Habitat - Vim and Vigor - They Don t Call Them High Bars For Nothin
http://www.tanashabitat.com/vim/0404151of6.asp Do you have a tummy ache that ver seems to go away? Do you wish your gu would just calm down and let you live your life? If so, you re not alo. You may suffer
More informationConstipation. What is constipation? What is the criteria for having constipation? What are the different types of constipation?
What is constipation? is defined as having a bowel movement less than 3 times per week. It is usually associated with hard stools or difficulty passing stools. You may have pain while passing stools or
More informationPsychosocial aspects of the functional gastrointestinal disorders
Gut 1999;45(Suppl II):II25 II30 II25 Psychosocial aspects of the functional gastrointestinal disorders D A Drossman, F H Creed, K W Olden, J Svedlund, B B Toner, W E Whitehead Chair, Committee on Psychosocial
More informationWhy it is important and how to achieve it.
Sustained behavioural change following bariatric surgery. Why it is important and how to achieve it. A/Prof Leah Brennan Australian Catholic University Centre for Eating, Weight and Body Image leah.brennan@acu.edu.au
More informationOPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES
OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES Introduction Introduction Mean faecal weight 128 g / cap / day Mean range 51-796 g Absolute range 15-1505 g Main factors affecting mass are caloric intake,
More informationAvoidant Coping Moderates the Association between Anxiety and Physical Functioning in Patients with Chronic Heart Failure
Avoidant Coping Moderates the Association between Anxiety and Physical Functioning in Patients with Chronic Heart Failure Eisenberg SA 1, Shen BJ 1, Singh K 1, Schwarz ER 2, Mallon SM 3 1 University of
More informationDealing with Feelings: The Effectiveness of Cognitive Behavioural Group Treatment for Women in Secure Settings
Behavioural and Cognitive Psychotherapy, 2011, 39, 243 247 First published online 30 November 2010 doi:10.1017/s1352465810000573 Dealing with Feelings: The Effectiveness of Cognitive Behavioural Group
More informationIBS Irritable Bowel syndrome Therapeutics II PHCL 430
Salman Bin AbdulAziz University College Of Pharmacy IBS Irritable Bowel syndrome Therapeutics II PHCL 430 Email:- ahmedadel.pharmd@gmail.com Ahmed A AlAmer PharmD R.S is 32-year-old woman experiences intermittent
More informationA questionnaire to help general practitioners plan cognitive behaviour therapy
Primary Care Mental Health 2006;4:00 00 # 2006 Radcliffe Publishing Research paper A questionnaire to help general practitioners plan cognitive behaviour therapy MS Vassiliadou Eginiton Hospital, Athens,
More informationWORKPLACE. Dr. ONG BENG KEAT Consultant Psychiatrist Psychological Medicine Clinic LohGuanLye Specialists Centre, Penang
STRESS @ WORKPLACE Dr. ONG BENG KEAT Consultant Psychiatrist Psychological Medicine Clinic LohGuanLye Specialists Centre, Penang Outline Introduction: What is stress? Sources of stress Stress and productivity
More informationISSN: Volume 1, Issue 3 (2013) Guru Journal of Behavioral and Social Sciences. Volume 1 Issue 3 (July Sept, 2013)
Volume 1 Issue 3 (July Sept, 2013) ISSN: 2320-9038 www.gjbss.org G.J. B. S. S Volume 1 Issue 3 2013 Editor Jayan, C Manikandan K State-Trait Anxiety and Co-morbid Depression among Anxiety Disorder Patients
More informationdepression and anxiety in later life clinical challenges and creative research
2 nd Annual MARC Symposium Critical Themes in Ageing Melbourne, 10 th August 2018 depression and anxiety in later life clinical challenges and creative research Nicola T Lautenschlager, MD, FRANZCP Professor
More informationComparison of Different Antidepressants and Psychotherapy in the Short-term Treatment of Depression
ORIGINAL COMPARISON PAPER OF DIFFERENT ANTIDEPRESSANTS AND PSYCHOTHERAPY IN THE SHORT-TERM TREATMENT OF DEPRESSION Comparison of Different Antidepressants and Psychotherapy in the Short-term Treatment
More informationResults. Assessment of IBS. Determination of Concordance
GASTROENTEROLOGY 2001;121:799 804 Irritable Bowel Syndrome in Twins: Heredity and Social Learning Both Contribute to Etiology RONA L. LEVY,* KENNETH R. JONES, WILLIAM E. WHITEHEAD, SHARA I. FELD, NICHOLAS
More informationCBT Treatment. Obsessive Compulsive Disorder
CBT Treatment Obsessive Compulsive Disorder 1 OCD DEFINITION AND DIAGNOSIS NORMAL WORRIES & COMPULSIONS DYSFUNCTIONAL/ABNORMAL OBSESSIONS DSM IV DIAGNOSIS 2 OCD DIAGNOSIS DSM IV & ICD 10 A significant
More informationJamie A. Micco, PhD APPLYING EXPOSURE AND RESPONSE PREVENTION TO YOUTH WITH PANDAS
APPLYING EXPOSURE AND RESPONSE PREVENTION TO YOUTH WITH PANDAS Jamie A. Micco, PhD Director, Intensive Outpatient Service Child and Adolescent Cognitive Behavioral Therapy Program Massachusetts General
More informationPathways to Inflated Responsibility Beliefs in Adolescent Obsessive-Compulsive Disorder: A Preliminary Investigation
Behavioural and Cognitive Psychotherapy, 2011, 39, 229 234 First published online 23 November 2010 doi:10.1017/s1352465810000810 Pathways to Inflated Responsibility Beliefs in Adolescent Obsessive-Compulsive
More information